We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 101-120 of 4,064 results
  1. Antimicrobial Stewardship: Evolution into the Twenty-First Century

    Overuse and inappropriate use of antimicrobials are the key drivers in the development of antibiotic resistance. Every year, at least two million...
    Robert W. Finberg, Roy Guharoy in Clinical Use of Anti-infective Agents
    Chapter 2021
  2. Antimicrobial Resistance in Food-Borne Campylobacter spp.

    Campylobacteriosis is one of the important reasons for food-related gastrointestinal infections across the world. The microaerophilic group of...
    Manjusha Lekshmi, Sanath H. Kumar, ... Manuel F. Varela in Handbook on Antimicrobial Resistance
    Reference work entry 2023
  3. Antimicrobial Resistance in Food-Borne Campylobacter spp.

    Campylobacteriosis is one of the important reasons for food-related gastrointestinal infections across the world. The microaerophilic group of...
    Manjusha Lekshmi, Sanath H. Kumar, ... Manuel F. Varela in Handbook on Antimicrobial Resistance
    Living reference work entry 2023
  4. Miltefosine Unresponsiveness in Visceral Leishmaniasis

    Treatment failure in visceral leishmaniasis (VL; kala-azar) is an increasing problem worldwide, primarily due to drug resistance. Pentavalent...
    Ruchi Singh, Aditya Verma, ... Poonam Salotra in Challenges and Solutions Against Visceral Leishmaniasis
    Chapter 2023
  5. Chemotherapy for Drug-Susceptible Tuberculosis

    The decade of 1940s brought one of the major achievements when streptomycinStreptomycin was discovered to treat tuberculosis (TB)–the first effective...
    Vinayak Singh, Nicole Cardoso, Stanislav Huszár in Tuberculosis
    Chapter 2023
  6. Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency

    Background

    Patients with an IgG subclass deficiency (IgSD) ± specific polysaccharide antibody deficiency (SPAD) often present with recurrent...

    Bas M. Smits, Ilona Kleine Budde, ... Joris M. van Montfrans in Journal of Clinical Immunology
    Article Open access 18 November 2020
  7. Comparison between culture-positive and culture-negative septic shock in patients in the emergency department

    Culture results of patients with septic shock affect their management strategies, including antibiotic administration. This study aimed to compare...

    Choon-Bing Chua, Chi-Chieh Hung, ... Yin-Chou Hsu in European Journal of Clinical Microbiology & Infectious Diseases
    Article 15 September 2022
  8. The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C

    Background

    Arginine auxotrophy constitutes a shortcoming for ~ 30% of glioblastoma multiforme (GBM). Indeed, arginine-depleting therapy using arginine...

    Charlotte Linke, Thomas Freitag, ... Claudia Maletzki in Cancer Cell International
    Article Open access 27 February 2023
  9. Gentamicin Dosing in Neonates with Normal Renal Function: Trough and Peak Levels

    Background and Objective

    Gentamicin is commonly used in neonates, and it requires drug concentration monitoring. The objective of this study was to...

    Kristin O’Connor, Mark W. Davies, ... Karen Whitfield in European Journal of Drug Metabolism and Pharmacokinetics
    Article 09 August 2021
  10. Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)

    Background

    Advanced pancreatic cancer is one of the leading causes of cancer-related deaths. For patients with advanced pancreatic cancer, gemcitabine...

    Hiroo Imai, Yasuhiro Sakamoto, ... Chikashi Ishioka in BMC Cancer
    Article Open access 24 February 2024
  11. Use of Nanoparticles in Multidrug Resistant Tuberculosis Diagnosis

    Tuberculosis (TB) is one of the main community health concerns causing millions of death every year globally. The irrational use of anti-tuberculosis...
    Aiswarya Chandrasekaran, G. H. R. Eranga Karunaratne in Nanotechnology for Infectious Diseases
    Chapter 2022
  12. Futuristic Potential of Nanoantibiotics Against Multidrug Resistant Tuberculosis

    Tuberculosis (TB) has been a worldwide health issue from the start of sixteenth as well as seventeeth centuries till the date, with new resistance...
    Pooja Sanjay Khairnar, Ajit Singh, Rahul Shukla in Nanotechnology for Infectious Diseases
    Chapter 2022
  13. The effect of an antibiotic stewardship program on tigecycline use in a Tertiary Care Hospital, an intervention study

    Background

    A drug-oriented antibiotic stewardship intervention targeting tigecycline utilization was launched at Makassed General Hospital, Beirut,...

    Rima Moghnieh, Dania Abdallah, ... Tamima Jisr in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 06 August 2020
  14. Current Progress and Prospects for a Buruli Ulcer Vaccine

    Buruli ulcer (BU), one of the skin-related neglected tropical diseases (skin NTDs), is a necrotizing and disabling cutaneous disease caused by...
    Justice Boakye-Appiah, Belinda Hall, ... Rachel E. Simmonds in Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges
    Chapter Open access 2023
  15. Fecal Microbiota Transplantation in Diseases Not Associated with Clostridium difficile: Current Status and Future Therapeutic Option

    Fecal microbiota transplantation (FMT) is one of several effective methods for modifying altered intestinal microbiota and treating certain...
    Sergii Tkach, Andrii Dorofeyev, ... Nazarii Kobyliak in Microbiome in 3P Medicine Strategies
    Chapter 2023
  16. Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series

    Background

    Dalbavancin is a semisynthetic antibiotic used as an alternative to vancomycin for skin infections and osteomyelitis. Its long half-life...

    Connor Evins, Harrison Lancaster, Amanda E. Schnee in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 26 April 2022
  17. Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR)

    Background

    Bloodstream infections (BSIs), or bacteremia, are responsible for considerable disease burden. Increasing rates of antibiotic resistance...

    Z. S. Khankhel, R. J. Dillon, ... L. Puzniak in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 03 October 2022
  18. Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy

    Background

    To evaluate the efficacy and safety of recombinant human serum albumin /granulocyte colony-stimulating factor (rHSA/G-CSF) in breast cancer...

    Shanshan Chen, Yiqun Han, ... Binghe Xu in BMC Cancer
    Article Open access 31 March 2021
  19. Current Reserve Drugs

    The incidence of resistance development against antimicrobial agents is increasing in Gram-negative bacteria (GNB) worldwide. This has resulted into...
    Chapter 2022
  20. New Anti-tuberculous Drugs: Bedaquiline, Delamanid, and Pretomanid

    Development of new drugs to treat drug-resistant tuberculosis is most important in the fight against the global spread of this contagious and...
    Chapter 2023
Did you find what you were looking for? Share feedback.